Published in J Mol Diagn on November 30, 2009
Evaluation of Signature Erosion in Ebola Virus Due to Genomic Drift and Its Impact on the Performance of Diagnostic Assays. Viruses (2015) 0.99
Assessing vertebrate biodiversity in a kelp forest ecosystem using environmental DNA. Mol Ecol (2015) 0.98
Resolving rates of mutation in the brain using single-neuron genomics. Elife (2016) 0.89
Evaluation of four endogenous reference genes and their real-time PCR assays for common wheat quantification in GMOs detection. PLoS One (2013) 0.82
Quantification of endospore-forming firmicutes by quantitative PCR with the functional gene spo0A. Appl Environ Microbiol (2013) 0.81
CYP2D6 Haplotype Determination Using Long Range Allele-Specific Amplification: Resolution of a Complex Genotype and a Discordant Genotype Involving the CYP2D6*59 Allele. J Mol Diagn (2015) 0.79
Design and Evaluation of Illumina MiSeq-Compatible, 18S rRNA Gene-Specific Primers for Improved Characterization of Mixed Phototrophic Communities. Appl Environ Microbiol (2016) 0.79
Differentiation of Salmonella strains from the SARA, SARB and SARC reference collections by using three genes PCR-RFLP and the 2100 Agilent Bioanalyzer. Front Microbiol (2014) 0.78
The Applicability of TaqMan-Based Quantitative Real-Time PCR Assays for Detecting and Enumerating Cryptosporidium spp. Oocysts in the Environment. PLoS One (2013) 0.78
G-quadruplex-generating polymerase chain reaction for visual colorimetric detection of amplicons. Anal Biochem (2013) 0.77
Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay. PLoS One (2015) 0.77
The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques. AIDS Res Hum Retroviruses (2015) 0.77
Reading Mammal Diversity from Flies: The Persistence Period of Amplifiable Mammal mtDNA in Blowfly Guts (Chrysomya megacephala) and a New DNA Mini-Barcode Target. PLoS One (2015) 0.77
Elucidation of Taste- and Odor-Producing Bacteria and Toxigenic Cyanobacteria in a Midwestern Drinking Water Supply Reservoir by Shotgun Metagenomic Analysis. Appl Environ Microbiol (2016) 0.76
Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies. Vet Immunol Immunopathol (2016) 0.75
Use of a Multiplex PCR for the Detection of Toxin-Encoding Genes netB and tpeL in Strains of Clostridium perfringens. ISRN Vet Sci (2013) 0.75
Experimental design to evaluate directed adaptive mutation in Mammalian cells. JMIR Res Protoc (2014) 0.75
Genetic Variability of HIV-1 for Drug Resistance Assay Development. Viruses (2016) 0.75
Evaluation of microbial qPCR workflows using engineered Saccharomyces cerevisiae. Biomol Detect Quantif (2016) 0.75
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment. PLoS One (2016) 0.75
A Tale of Tails: Dissecting the Enhancing Effect of Tailed Primers in Real-Time PCR. PLoS One (2016) 0.75
Generic Amplicon Deep Sequencing to Determine Ilarvirus Species Diversity in Australian Prunus. Front Microbiol (2017) 0.75
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res (1990) 9.28
Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol (2002) 6.88
Real-time PCR in virology. Nucleic Acids Res (2002) 6.71
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci U S A (1994) 4.86
DNA polymerase fidelity and the polymerase chain reaction. PCR Methods Appl (1991) 4.31
Extension of base mispairs by Taq DNA polymerase: implications for single nucleotide discrimination in PCR. Nucleic Acids Res (1992) 3.74
Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry (1991) 3.54
Base mispair extension kinetics. Comparison of DNA polymerase alpha and reverse transcriptase. J Biol Chem (1990) 3.38
Structures of mismatch replication errors observed in a DNA polymerase. Cell (2004) 2.70
Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clin Chem (2006) 2.32
The power of real-time PCR. Adv Physiol Educ (2005) 2.21
Advances in quantitative PCR technology: 5' nuclease assays. Curr Opin Biotechnol (1998) 1.93
Polymerase chain reaction strategy. Annu Rev Biochem (1992) 1.88
Sequence variation in primer targets affects the accuracy of viral quantitative PCR. J Clin Virol (2005) 1.80
Influence of DNA structure on DNA polymerase beta active site function: extension of mutagenic DNA intermediates. J Biol Chem (2004) 1.62
Quantification of the detrimental effect of a single primer-template mismatch by real-time PCR using the 16S rRNA gene as an example. Appl Environ Microbiol (2008) 1.42
Specificity, efficiency, and fidelity of PCR. PCR Methods Appl (1993) 1.35
The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies. Nucleic Acids Res (1997) 1.31
Reactions at the polymerase active site that contribute to the fidelity of Escherichia coli DNA polymerase I (Klenow fragment). J Biol Chem (1992) 1.29
Base mispair extension kinetics. Binding of avian myeloblastosis reverse transcriptase to matched and mismatched base pair termini. J Biol Chem (1992) 1.22
Misincorporation and mispaired primer extension by human immunodeficiency virus reverse transcriptase. J Biol Chem (1994) 1.20
Nucleotide analogs facilitate base conversion with 3' mismatch primers. Nucleic Acids Res (1999) 1.20
The use of real-time PCR methods in DNA sequence variation analysis. Clin Chim Acta (2005) 1.14
The effects of sequence length and oligonucleotide mismatches on 5' exonuclease assay efficiency. Nucleic Acids Res (2002) 1.10
Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J Acquir Immune Defic Syndr (2001) 1.07
Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beacons. J Clin Virol (2005) 0.79
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog (2007) 6.04
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis (2005) 2.90
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology (2010) 1.98
Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med (2013) 1.95
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J Clin Microbiol (2008) 1.85
Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood (2013) 1.77
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy. J Hepatol (2008) 1.71
Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis (2014) 1.59
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology (2008) 1.56
Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population. Clin Pharmacokinet (2003) 1.43
Fatal oseltamivir-resistant influenza virus infection. N Engl J Med (2008) 1.39
Novel hepatitis E virus in ferrets, the Netherlands. Emerg Infect Dis (2012) 1.38
Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol (2010) 1.37
Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology (2014) 1.33
Quantitative real-time PCR on Lightcycler for the detection of human immunodeficiency virus type 2 (HIV-2). J Virol Methods (2004) 1.27
Neuralgic amyotrophy and hepatitis E virus infection. Neurology (2014) 1.15
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients. AIDS (2003) 1.15
Validation of self-swab for virologic confirmation of influenza virus infections in a community setting. J Infect Dis (2011) 1.15
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog (2012) 1.13
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis (2013) 1.12
September through October 2010 multi-centre study in the Netherlands examining laboratory ability to detect enterovirus 68, an emerging respiratory pathogen. J Virol Methods (2013) 1.10
Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets. PLoS Pathog (2011) 1.09
Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1. Clin Infect Dis (2002) 1.07
Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant. J Clin Virol (2009) 1.07
Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients. Scand J Infect Dis (2012) 1.07
Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog (2013) 1.04
Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy. J Med Microbiol (2002) 1.00
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res (2011) 0.97
Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B. Hepatology (2012) 0.96
Comparison of the efficacy of early versus late viral proteins in vaccination against SIV. Vaccine (2002) 0.95
Real-time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection. J Clin Virol (2011) 0.95
Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction. J Virol (2002) 0.94
Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis (2009) 0.94
The potential for multidrug-resistant influenza. Curr Opin Infect Dis (2011) 0.93
Influenza virus resistance to antiviral therapy. Adv Pharmacol (2013) 0.92
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene. J Clin Microbiol (2007) 0.89
Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant (2013) 0.87
A family-wide RT-PCR assay for detection of paramyxoviruses and application to a large-scale surveillance study. PLoS One (2012) 0.87
Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy. Clin Infect Dis (2005) 0.86
Hepatitis e virus: current concepts and future perspectives. Curr Infect Dis Rep (2014) 0.86
Avian influenza a virus in wild birds in highly urbanized areas. PLoS One (2012) 0.86
Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV. J Med Virol (2013) 0.85
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients. Vaccine (2012) 0.84
Adenovirus DNA positivity in nasopharyngeal aspirate preceding hematopoietic stem cell transplantation: a very strong risk factor for adenovirus DNAemia in pediatric patients. Clin Infect Dis (2009) 0.84
Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations. J Mol Diagn (2013) 0.82
Hepatitis E virus infection in hematopoietic stem cell transplant recipients. Curr Opin Infect Dis (2014) 0.82
VIRO-TypeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014. Euro Surveill (2016) 0.82
Therapy failure resulting from superinfection by a drug-resistant HIV variant. Antivir Ther (2012) 0.81
Mapping QTL influencing gastrointestinal nematode burden in Dutch Holstein-Friesian dairy cattle. BMC Genomics (2009) 0.81
Satisfying the need for rapid diagnosis of new variant influenza A H1N1. Expert Rev Mol Diagn (2010) 0.81
Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: improvement and implementation. J Virol Methods (2012) 0.81
Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients. Eur J Gastroenterol Hepatol (2005) 0.80
Genotypic anomaly in Ebola virus strains circulating in Magazine Wharf area, Freetown, Sierra Leone, 2015. Euro Surveill (2015) 0.79
HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes. J Acquir Immune Defic Syndr (2004) 0.79
The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients. Liver Int (2014) 0.78
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats. J Gen Virol (2004) 0.78
Performance of a nurse-led paediatric point of care service for respiratory syncytial virus testing in secondary care. J Infect (2010) 0.78
Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS). Antivir Ther (2015) 0.77
Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA. Vet Immunol Immunopathol (2008) 0.77
HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption. AIDS (2013) 0.76
HIV-2 encephalitis: case report and literature review. AIDS Patient Care STDS (2012) 0.76
An improved approach to identify epidemiological and phylogenetic transmission pairs of source and contact tracing of hepatitis B. J Med Virol (2009) 0.76
Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia. J Med Virol (2013) 0.76
Increase in ECHOvirus 6 infections associated with neurological symptoms in the Netherlands, June to August 2016. Euro Surveill (2016) 0.76
Population genetic tests suggest that the epidemiologies of JCV and BKV are strikingly different. Infect Genet Evol (2009) 0.76
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats. Vaccine (2008) 0.76
Hepatitis B e antigen levels and response to peginterferon: influence of precore and basal core promoter mutants. Antiviral Res (2012) 0.75
Follow-up of Contacts of Middle East Respiratory Syndrome Coronavirus-Infected Returning Travelers, the Netherlands, 2014. Emerg Infect Dis (2015) 0.75
Persistence of YMDD variants after withdrawal of Lamivudine. J Hepatol (2002) 0.75
Discordance between HCV RNA assays for week 24 HCV RNA determination during pegylated interferon-α/ribavirin treatment for chronic hepatitis C. Antivir Ther (2011) 0.75
Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. J Clin Virol (2009) 0.75
A 5-year study of adenoviruses causing conjunctivitis in Izmir, Turkey. J Med Virol (2014) 0.75
Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha. AIDS (2007) 0.75